A Study of Past Experimental Treatment With Dexmedetomidine in Patients With Renal Transplants

This retrospective study will examine the use of Dexmedtomidine in renal transplants.

a study on Renal Failure Kidney Transplant

Summary

Eligibility
for people ages 18 years and up (full criteria)
Location
at Sacramento, California
Dates
study started
estimated completion
Principal Investigator
by Hong Liu, M.D.

Description

Summary

Investigators aim to retrospectively research patients undergoing renal transplants that received dexmedetomidine perioperatively to see if dexmedetomidine use protects renal function. Investigators hope to elucidate any association between renal transplant patients and perioperative dexmedetomidine administration, these include (but are not limited to) UOP, Cr/GFR, morbidity, mortality, in hospital complications and failure rate. Investigators will research both living and cadaveric renal transplants.

Official Title

Dexmedetomidine and Renal Transplants

Keywords

Renal Failure Renal Insufficiency

Eligibility

You can join if…

Open to people ages 18 years and up

Patients greater than or equal to 18 years old that underwent renal transplant at UC Davis Medical Center -

You CAN'T join if...

Patients that did not undergo renal transplants and patients less than 18 years old will be excluded from the study.

-

Location

  • UC Davis Health System
    Sacramento California 95817 United States

Lead Scientist at UC Davis

  • Hong Liu, M.D.
    Professor, Anesthesiology and Pain Medicine. Authored (or co-authored) 80 research publications

Details

Status
accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
University of California, Davis
Links
Sign up for this study
ID
NCT02019121
Study Type
Observational
Participants
Expecting 5000 study participants
Last Updated
Contact us about this trial